More than 50 years ago individuals with polio courageously led the challenge of maintaining mechanical ventilation outside of institutions and quietly initiated a more independent, patient-centered and collaborative approach to respiratory health care. Today, the drivers for home mechanical ventilation (HMV) are different. The rising costs of hospital care, the advent of commercially available noninvasive masks and positive pressure ventilators, have fuelled greater demand for HMV. However, the desire of individuals to maintain a quality of life (QoL) in their homes remains the prevailing impetus. The present HMV clinical practice guideline is intended to be a resource for physicians, healthcare providers, policymakers and individuals at risk for or currently using ventilatory support in the home. The objective is to identify and support ventilated patients who are presently at home, as well as those transitioning to home-based care, where QoL is the greatest and costs are minimized. Developed by The Canadian Thoracic Society (CTS), these guidelines intend to provide the most up-to-date information and evidence-based recommendations to enable practitioners to manage the provision of preventive airway management and home ventilation.
These guidelines are composed of disease-specific sections in addition to overriding subjects such as ethical considerations, transition to home and airway clearance. In the discipline of respiratory medicine there are extremely few prospective or randomized trials. As a result, most recommendations are based on retrospective or descriptive studies and, to a great extent, on consensus of the CTS HMV committee.
Recommendations strive to achieve a balance between an exceptional standard of care illustrated in the literature and the reality of healthcare in Canada where geographicalhealth care and economic barriers may require compromise to ensure the availability of the best care possible. This approach may also allow greater applicability to jurisdictions where, for example, polysomnography may be unavailable or so difficult to obtain as to present unacceptable barriers to appropriate, timely introduction of noninvasive ventilation (NIV). Nevertheless, some subjects considered to be important by the committee are not addressed in the literature. Some jurisdictions have access to provincial ventilator pools, in which equipment and knowledgeable health care professionals are available at relatively minimal cost, to ensure the success of HMV. The literature does not address questions regarding government-funded equipment pools. On important issues for which literature is lacking, but strong expert opinion was available, recommendations were made by the HMV Guideline Committee.
No article in the literature, to our knowledge, addressed the appropriate addition of a back-up ventilation system aside from patients fully ventilated through a tracheostomy; accordingly, it remains uncertain as to precisely when an individual on NIV should have an additional ventilator or when alarms should be required. The general recognition that NIV is not designed for full 24h life support has resulted in this uncertainty. However, patients are, in fact, using 24h NIV, without which they are at risk for acute respiratory failure. This area of risk management will need attention in future investigation.Throughout the recommendations; it is assumed (aside from that clearly stated in the section on Transition to Home) that appropriate training will be provided to patients and caregivers.
These guidelines do not address negative-pressure body ventilators or abdominal ventilators because positive-pressure ventilators have, with few exceptions, completely replaced negative-pressure ventilators in the home. Although potentially of significant clinical value in the follow-up of patients on NIV, no recommendations are made on the use of digital information and downloads from bilevel devices. Additional research is desperately needed to address many of these critical questions.
机械通气攻略 2011年CTS家庭机械通气攻略
精彩推荐
- 问界新M5 Ultra与特斯拉Model Y,谁才是智慧出行伙伴?
金秋十月,正值传统购车旺季,汽车市场也迎来了一轮新品投放与促销热潮。对于众多持币待购的消费者而言,在竞争激烈的中型智能SUV市场中做出选择并非易事。其中,华为深度...详细
- 聚焦20-30万级智能SUV,问界新M5 Ultra与小米YU7谁更值得入?
在20万-30万元新能源SUV市场,问界新M5 Ultra与小米YU7凭借突出的智能属性,成为都市精英群体的热门选择。两款车型均以辅助驾驶为核心卖点,但在实际体验、安全理念与市场...详细
- 鸿蒙智行以“成长型汽车”破局,与老用户共赴智能新程
9月23日,鸿蒙智行宣布启动重磅升级,带来包括华为乾崑智驾ADS 4在内的3大能力升级和30余项体验优化。在智能汽车行业买定即落后的普遍焦虑下,鸿蒙智行选择让汽车像电子产...详细
- 极氪9X重磅发布,开启中国豪华旗舰SUV的新时代
9月29日,极氪旗下全球超豪华SUV新旗舰极氪9X正式上市,共推出Max版、Ultra版、Hyper版、曜黑版四个版型,官方零售价分别为46.59万元起、48.59万元起、55.99万元起、曜黑版...详细
本周热门
- 同仁堂健康双十一活动开启 “象食养医”倡导从健康的时候就关注健康
如果你想了解自己身体的秘密,让健康成为日常的生活方式,保持年轻的状态,实现抗衰老,逆生长的美好愿望,那么今年双十一的这场活动你一定不要错过。11月1日,同仁堂健康...详细